1. Wulffraat NM, Haas PJ, Frosch M, de Kleer IM, Vogl T, Brinkman DMC, Quartier P, Roth J, Kuis W. Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Annals of the Rheumatic Diseases.62:236-241 (2003)
2. von Stebut E, Ehrchen JM, Belkaid Y, Kostka SL, Molle K, Knop J, Sunderkotter C, Udey MC. Interleukin 1 alpha promotes Th-1 differentiation and inhibits disease progression in Leishmania major - Susceptible BALB/c mice. Journal of Experimental Medicine.198:191-199 (2003)
3. van Lent P, Nabbe KC, Boross P, Blom AB, Roth J, Holthuysen A, Sloetjes A, Verbeek S, van den Berg W. The inhibitory receptor Fc gamma RII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of Fc gamma RI/III but also by efficient clearance and endocytosis of immune complexes. American Journal of Pathology.163:1839-1848 (2003)
4. Stroh C, Held E, Samraj AK, Schulze-Osthoff K. Specific inhibition of transcription factor NF-kappa B through intracellular protein delivery of I kappa B alpha by the Herpes virus protein VP22. Oncogene.22:5367-5373 (2003)
5. Seeliger S, Vogl T, Engels IH, Schroder JM, Sorg C, Sunderkotter C, Roth J. Expression of Calcium-Binding Proteins MRP8 and MRP14 in Inflammatory Muscle Diseases. Am J Pathol.163:947-956. (2003)
6. Seeliger S, Derian CK, Vergnolle N, Bunnett NW, Nawroth R, Schmelz M, von der Weid PY, Buddenkotte J, Sunderkotter C, Metze D, Andrade-Gordon P, Harms E, Vestweber D, Luger TA, Steinhoff M. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. Faseb Journal.17:1871-1885 (2003)
7. Schonlau F, Schlesiger C, Ehrehen J, Grabbe S, Sorg C, Sunderkotter C. Monocyte and macrophage functions in M-CSF-deficient op/op mice during experimental leishmaniasis. Journal of Leukocyte Biology.73:564-573 (2003)
8. Scholzen TE, Sunderkotter C, Kalden DH, Brzoska T, Fastrich M, Fisbeck T, Armstrong CA, Ansel JC, Luger TA. alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology.144:360-370 (2003)
9. Rudack C, Maune S, Eble J, Schroeder JM. The primary role in biologic activity of the neutrophil chemokines IL-81 and GRO-alpha in cultured nasal epithelial cells. Journal of Interferon and Cytokine Research.23:113-123 (2003)
10. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends in Immunology.24:155-158 (2003)
11. Roth J, Vogl T, Sunderkotter C, Sorg C. Chemotactic activity of S100A8 and S100A9. Journal of Immunology.171:5651-5651 (2003)
12. Renz A, Los M. Comments on the estimation of cell membrane alteration after drug treatment by LDH release - Response. Blood.101:2895-2895 (2003)
13. Nacken W, Roth J, Sorg C, Kerkhoff C. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microscopy Research and Technique.60:569-580 (2003)
14. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, Nacken W. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Molecular and Cellular Biology.23:1034-1043 (2003)
15. Maeda SM, Rotta O, Michalany NS, Camargo ZP, Sunderkotter C, Tomimori-Yamashita J. Comparison between anti-PGL-I serology and Mitsuda reaction: clinical reading, microscopic findings and immunohistochemical analysis. Leprosy Review.74:263-274 (2003)
16. Los M, Burek CJ, Stroh C, Benedyk K, Hug H, Mackiewicz A. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discovery Today.8:67-77 (2003)
17. Kess D, Peters T, Zamek J, Wickenhauser C, Tawadros S, Loser K, Varga G, Grabbe S, Nischt R, Sunderkotter C, Muller W, Krieg T, Scharffetter-Kochanek K. CD4(+) T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis. Journal of Immunology.171:5697-5706 (2003)
18. Fuellen G, Foell D, Nacken W, Sorg C, Kerkhoff C. Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction. Trends in Immunology.24:622-624 (2003)
19. Frosch M, Vogl T, Seeliger S, Wulffraat N, Kuis W, Viemann D, Foell D, Sorg C, Sunderkotter C, Roth J. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis and Rheumatism.48:2622-2626 (2003)
20. Foell D, Ichida F, Vogl T, Yu XY, Chen R, Miyawaki T, Sorg C, Roth J. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet.361:1270-1272 (2003)
21. Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut.52:847-853 (2003)
22. Foell D, Seeliger S, Vogl T, Koch HG, Maschek H, Harms E, Sorg C, Roth J. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax.58:613-617 (2003)
23. Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, FitzGerald O, Roth J. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology.42:1383-1389 (2003)
24. Cassens U, Lewinski G, Samraj AK, von Bernuth H, Baust H, Khazaie K, Los M. Viral modulation of cell death by inhibition of caspases. Archivum Immunologiae Et Therapiae Experimentalis.51:19-27 (2003)
25. Baust H, Schoke A, Brey A, Gern U, Los M, Schmid RM, Rottinger EM, Seufferlein T. Evidence for radiosensitizing by gliotoxin in HL-60 cells: implications for a role of NF-kappa B independent mechanisms. Oncogene.22:8786-8796 (2003)